ImportRefusal LogoImportRefusal

HIKMA PHARMACEUTICALS USA INC

⚠️ High Risk

FEI: 3017452050 • Berkeley Heights, NJ • UNITED STATES

FEI

FEI Number

3017452050

📍

Location

Berkeley Heights, NJ

🇺🇸
🏢

Address

200 Connell Dr Ste 4000, , Berkeley Heights, NJ, United States

High Risk

FDA Import Risk Assessment

51.1
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

4
Total Refusals
3
Unique Violations
5/13/2025
Latest Refusal
4/12/2021
Earliest Refusal

Score Breakdown

Violation Severity
70.0×40%
Refusal Volume
25.9×30%
Recency
71.9×20%
Frequency
9.8×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1792×

AGR RX

The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

Refusal History

DateProductViolationsDivision
5/13/2025
60RCA18ORLISTAT/TETRAHYDROLIPSTATIN (ANOREXIC)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/12/2024
61KCK22GLYCOPYRROLATE (ANTI-CHOLINERGIC)
179AGR RX
Division of Northeast Imports (DNEI)
2/12/2024
60CCK09PHENYLEPHRINE HCL (ADRENERGIC)
179AGR RX
Division of Northeast Imports (DNEI)
4/12/2021
64LCA50PREDNISOLONE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is HIKMA PHARMACEUTICALS USA INC's FDA import refusal history?

HIKMA PHARMACEUTICALS USA INC (FEI: 3017452050) has 4 FDA import refusal record(s) in our database, spanning from 4/12/2021 to 5/13/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. HIKMA PHARMACEUTICALS USA INC's FEI number is 3017452050.

What types of violations has HIKMA PHARMACEUTICALS USA INC received?

HIKMA PHARMACEUTICALS USA INC has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about HIKMA PHARMACEUTICALS USA INC come from?

All FDA import refusal data for HIKMA PHARMACEUTICALS USA INC is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.